Related Experiment Video

Updated: Nov 5, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.0K

Idiopathic Thrombocytopenic Purpura Related to COVID-19

Mariana M Langhi1, Andre N R Abdo1, Juliana F B Putz1

  • 1Oncology Center at Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil.

Journal of Medical Cases
|May 13, 2021
PubMed

Insights

Idiopathic thrombocytopenic purpura (ITP) patients may experience worsening platelet counts during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This case highlights a potential link between COVID-19 and ITP complications.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Virology

Background:

  • The global spread of coronavirus disease 2019 (COVID-19) has raised questions about its potential complications.
  • Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet counts.

Observation:

  • A patient with previously controlled idiopathic thrombocytopenic purpura (ITP) developed a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
  • The patient exhibited a significant decrease in platelet count during the SARS-CoV-2 infection.

Findings:

  • A potential association between SARS-CoV-2 infection and worsening thrombocytopenia in a patient with pre-existing ITP was observed.
  • Other potential causes of thrombocytopenia were excluded, strengthening the link to the viral infection.

Implications:

  • This case suggests that SARS-CoV-2 infection may exacerbate underlying conditions like ITP.
  • Further research is needed to understand the mechanisms linking COVID-19 and thrombocytopenia in ITP patients.
  • Clinicians should consider monitoring platelet counts closely in ITP patients who contract COVID-19.

Keywords:
COVID-19ITPThrombocytopenia

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

854
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.1K

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
88
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
79
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
991